Address https://gelex.eu/eli/EU/act/2009/2@2009-01-15/en

Contents

1. Preamble
2. 1. Article 1
   2. Article 2
   3. Article 3
   4. Article 4
3. ANNEX
4. ANNEX 1A
5. ANNEX 1B
6. ANNEX 1C

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances, and in particular Article 28 thereof,

Whereas:

(1) Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.

(2) Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.

(3) Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.

(4) Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.

(5) Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.

(6) The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

(7) As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.

(8) The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.

(9) The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,

HAS ADOPTED THIS DIRECTIVE:

Article 1

Directive 67/548/EEC is amended as follows. Annex I is amended as follows:

(a) the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;

(b) the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;

(c) the entries set out in Annex 1C to this Directive are deleted.

Article 2

Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive. When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made. Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.

Article 3

This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Article 4

This Directive is addressed to the Member States.

Done at Brussels, 15 January 2009. For the Commission Stavros Dimas Member of the Commission

ANNEX

ANNEX 1A

Index No Chemical name Notes related to substances EC No CAS No Classification Labelling Concentration Limits Notes related to preparations 001-002-00-4 aluminium lithium hydride 240-877-9 16853-85-3 F; R15 C; R35 F; C R: 15-35 S: (1/2-)7/8-26-36/37/39-43-45 005-006-00-7 dibutyltin hydrogen borate E 401-040-5 75113-37-0 Muta. Cat. 3; R68 Repr. Cat. 2; R60-61 T; R48/25 Xn; R21/22 Xi; R41 R43 N; R50-53 T; N R: 60-61-21/22-41-43-48/25-68-50/53 S: 53-45-60-61 006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex A — — T+; R26/27/28 R32 N; R50-53 T+; N R: 26/27/28-32-50/53 S: (1/2-)7-28-29-45-60-61 006-015-00-9 diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4 330-54-1 Carc. Cat. 3; R40 Xn; R22-48/22 N; R50-53 Xn; N R: 22-40-48/22-50/53 S: (2-)13-36/37-46-60-61 C ≥ 25 %: Xn, N; R22-40-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53 2,5 % ≤ C < 10 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 006-076-00-1 mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt — 8018-01-7 Repr. Cat. 3; R63 R43 N; R50 Xn; N R: 43-63-50 S: (2-)36/37-46-61 C ≥ 5 %: Xn, N; R43-63-50 2,5 ≤ C < 5 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 006-077-00-7 maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) 235-654-8 12427-38-2 Repr. Cat. 3; R63 Xn; R20 Xi; R36 R43 N; R50-53 Xn; N R: 20-36-43-63-50/53 S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R20-36-43-63-50/53 20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53 5 % ≤ C < 20 %: Xn, N; R43-63-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 006-084-00-5 carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate 259-565-9 55285-14-8 T+; R26 T; R25 R43 N; R50-53 T+; N R: 25-26-43-50/53 S: (1/2-)28-36/37-38-45-63-60-61 006-088-00-7 benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate — 82560-54-1 Repr. Cat. 3; R62 T; R23 Xn; R22 N; R50-53 T; N R: 22-23-62-50/53 S: (1/2-)36/37-45-60-61 007-002-00-0 nitrogen dioxide; [1] dinitrogen tetraoxide [2] 233-272-6 [1] 234-126-4 [2] 10102-44-0 [1] 10544-72-6 [2] O; R8 T+; R26 C; R34 O; T+ R: 8-26-34 S: (1/2-)9-26-28-36/37/39-45 C ≥ 10 %: T+; R26-34 5 % ≤ C < 10 %: T; R23-34 1 % ≤ C < 5 %: T; R23-36/37/38 0,5 % ≤ C < 1 %: Xn; R20-36/37/38 0,1 % ≤ C < 0,5 %: Xn; R20 5 015-041-00-X malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion] 204-497-7 121-75-5 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-46-60-61 C ≥ 25 %: Xn, N; R22-43-50/53 1 % ≤ C < 25 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 015-100-00-X phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-3 14816-18-3 Repr. Cat. 3; R62 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-62-50/53 S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R22-43-62-50/53 5 % ≤ C < 25 %: Xn, N; R43-62-50/53 1 % ≤ C < 5 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 015-102-00-0 tris(2-chloroethyl)phosphate E 204-118-5 115-96-8 Carc. Cat. 3; R40 Repr. Cat. 2; R60 Xn; R22 N; R51-53 T; N R: 60-22-40-51/53 S: 53-45-61 015-155-00-X glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate E 278-636-5 77182-82-2 Repr. Cat. 2; R60 Repr. Cat. 3; R63 Xn; R20/21/22-48/20/22 T R: 60-20/21/22-48/20/22-63 S: 53-45 016-009-00-8 disodium sulfide; sodium sulfide 215-211-5 1313-82-2 T; R24 Xn; R22 C; R34 R31 N; R50 T; C; N R: 22-24-31-34-50 S: (1/2-)26-36/37/39-45-61 017-009-00-0 ammonium perchlorate; [containing ≥ 80 % of 0-30 μm particles] T 232-235-1 7790-98-9 E; R3 O; R9 E R: 3-9 S: (2-)14-16-36/37 024-004-00-7 sodium dichromate E 234-190-3 10588-01-9 O; R8 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 T+; R26 T; R25-48/23 Xn; R21 C; R34 R42/43 N; R50-53 O; T+; N R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53 S: 53-45-60-61 C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53 10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53 7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53 5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53 3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53 2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53 1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53 0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53 0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53 0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43 0,1 % ≤ C < 0,2 %: T; R45-46-20 3 027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 027-003-00-X cobalt sulfide 215-273-3 1317-42-6 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-60-61 C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 028-003-00-2 nickel monoxide; [1] nickel oxide; [2] bunsenite [3] E 215-215-7 [1] 234-323-5 [2] - [3] 1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] Carc. Cat. 1; R49 T; R48/23 R43 R53 T R: 49-43-48/23-53 S: 53-45-61 028-004-00-8 nickel dioxide E 234-823-3 12035-36-8 Carc. Cat. 1; R49 T; R48/23 R43 R53 T R: 49-43-48/23-53 S: 53-45-61 028-005-00-3 dinickel trioxide E 215-217-8 1314-06-3 Carc. Cat. 1; R49 T; R48/23 R43 R53 T R: 49-43-48/23-53 S: 53-45-61 028-006-00-9 nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] E 240-841-2 [1] 234-349-7 [2] - [3] 16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 028-007-00-4 trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] E 234-829-6 [1] - [2] 12035-72-2 [1] 12035-71-1 [2] Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 028-008-00-X nickel dihydroxide; [1] nickel hydroxide [2] E 235-008-5 [1] 234-348-1 [2] 12054-48-7 [1] 11113-74-9 [2] Carc. Cat. 1; R49 Repr. Cat. 2; R61 Muta. Cat. 3; R68 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 407-580-8 130201-51-3 Xi; R41 Xi R: 41 S: (2-)26-39 033-005-00-1 arsenic acid and its salts with the exception of those specified elsewhere in this Annex AE — — Carc. Cat. 1; R45 T; R23/25 N; R50-53 T; N R: 45-23/25-50/53 S: 53-45-60-61 034-002-00-8 selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex A — — T; R23/25 R33 N; R50-53 T; N R: 23/25-33-50/53 S: (1/2-)20/21-28-45-60-61 047-001-00-2 silver nitrate 231-853-9 7761-88-8 O; R8 C; R34 N; R50-53 O; C; N R: 8-34-50/53 S: (1/2-)26-36/37/39-45-60-61 050-002-00-0 cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide 236-049-1 13121-70-5 Xn; R20/21/22 N; R50-53 Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 C ≥ 25 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 25 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 050-003-00-6 fentin acetate (ISO); triphenyltin acetate 212-984-0 900-95-8 Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 050-004-00-1 fentin hydroxide (ISO); triphenyltin hydroxide 200-990-6 76-87-9 Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex A — — T; R25-48/23/25 Xn; R21 Xi; R36/38 N; R50-53 T; N R: 21-25-36/38-48/23/25-50/53 S: (1/2-)36/37/39-45-60-61 C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53 1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53 0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53 0,025 % C < 0,25 %: R52/53 1 050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex A — — T; R23/24/25 N; R50-53 T; N R: 23/24/25-50/53 S: (1/2-)26-27-28-45-60-61 C ≥ 1 %: T, N; R23/24/25-50/53 0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 1 050-018-00-8 tin(II) methanesulphonate 401-640-7 53408-94-9 C; R34 Xn; R22 R43 N; R51-53 C; N R: 22-34-43-51/53 S: (1/2-)22-26-36/37/39-45-61 053-003-00-4 iodoxybenzene — 696-33-3 E; R2 E R: 2 S: (2-)35 053-004-00-X calcium iodoxybenzoate C — — E; R2 E R: 2 S: (2-)35 080-001-00-0 mercury E 231-106-7 7439-97-6 Repr. Cat. 2; R61 T+; R26 T; R48/23 N; R50-53 T+; N R: 61-26-48/23-50/53 S: 53-45-60-61 080-010-00-X mercury dichloride; mercuric chloride 231-299-8 7487-94-7 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T+; R28 T; R48/24/25 C; R34 N; R50-53 T+; N R: 28-34-48/24/25-62-68-50/53 S: (1/2-)26-36/37/39-45-60-61 092-002-00-3 uranium compounds with the exception of those specified elsewhere in this Annex A — — T+; R26/28 R33 N; R51-53 T+; N R: 26/28-33-51/53 S: (1/2-)20/21-45-61 601-065-00-3 A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane); (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane) 416-930-9 — Xi; R38 N; R51-53 Xi; N R: 38-51/53 S: (2-)36/37-61 602-007-00-X bromoform; tribromomethane 200-854-6 75-25-2 T; R23 Xn; R22 Xi; R36/38 N; R51-53 T; N R: 22-23-36/38-51/53 S: (1/2-)28-45-63-61 602-030-00-5 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] C D 208-826-5 [1] 233-195-8 [2] 542-75-6 [1] 10061-01-5 [2] R10 T; R24/25 Xn; R20-65 Xi; R36/37/38 R43 N; R50-53 T; N R: 10-20-24/25-36/37/38-43-65-50/53 S: (1/2-)36/37-45-60-61 602-054-00-6 3-iodpropene; allyl iodide 209-130-4 556-56-9 F; R11 C; R34 F; C R: 11-34 S: (1/2-)7-16-26-45 603-005-00-1 2-methylpropan-2-ol; tert-butyl alcohol 200-889-7 75-65-0 F; R11 Xn; R20 Xi; R36/37 F; Xn R: 11-20-36/37 S: (2-)9-16-46 603-018-00-2 furfuryl alcohol 202-626-1 98-00-0 Carc. Cat. 3; R40 T; R23 Xn; R21/22-48/20 Xi; R36/37 T R: 21/22-23-36/37-40-48/20 S: (1/2-)36/37-45-63 603-023-00-X ethylene oxide; oxirane E 200-849-9 75-21-8 F+; R12 R6 Carc. Cat. 2; R45 Muta. Cat. 2; R46 T; R23 Xi; R36/37/38 F+; T R: 45-46-6-12-23-36/37/38 S: 53-45 603-029-00-2 bis(2-chloroethyl) ether 203-870-1 111-44-4 Carc. Cat. 3; R40 T+; R26/27/28 T+ R: 26/27/28-40 S: (1/2-)7/9-27-28-36/37-45 C ≥ 7 %: T+; R26/27/28-40 1 % ≤ C < 7 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 603-037-00-6 cellulose nitrate; nitrocellulose T — — E; R3 E R: 3 S: (2-)35 603-046-00-5 bis(chloromethyl) ether; oxybis(chloromethane) E 208-832-8 542-88-1 F; R11 Carc. Cat. 1; R45 T+; R26 T; R24 Xn; R22 F; T+ R: 45-11-22-24-26 S: 53-45 C ≥ 25 %: T+; R45-22-24-26 7 % ≤ C < 25 %: T+; R45-21-26 3 % ≤ C < 7 %: T; R45-21-23 1 % ≤ C < 3 %: T; R45-23 0,1 % ≤ C < 1 %: T; R45-20 0,001 % ≤ C < 0,1 %: T; R45 603-064-00-3 1-methoxy-2-propanol; monopropylene glycol methyl ether 203-539-1 107-98-2 R10 R67 R: 10-67 S: (2-) 603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide 203-437-7 106-87-6 Carc. Cat. 3; R40 T; R23/24/25 T R: 23/24/25-40 S: (1/2-)36/37-45-63 C ≥ 1 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde 204-639-8 123-63-7 R10 R: 10 S: (2-)29 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde 203-600-2 108-62-3 F; R11 Xn; R22 F; Xn R: 11-22 S: (2-)13-16-25-46 606-021-00-7 N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone 212-828-1 872-50-4 Repr. Cat. 2; R61 Xi; R36/37/38 T R: 61-36/37/38 S: 53-45 C ≥ 10 %: T; R61-36/37/38 5 % ≤ C < 10 %: T; R61 607-007-00-3 salts of oxalic acid with the exception of those specified elsewhere in this Annex A — — Xn; R21/22 Xn R: 21/22 S: (2-)24/25 C ≥ 5 %: Xn; R21/22 607-012-00-0 benzoyl chloride 202-710-8 98-88-4 Xn; R20/21/22 C; R34 R43 C R: 20/21/22-34-43 S: (1/2-)26-36/37/39-45 607-037-00-7 2-ethoxyethyl acetate; ethylglycol acetate E 203-839-2 111-15-9 R10 Repr. Cat. 2; R60-61 Xn; R20/21/22 T R: 60-61-10-20/21/22 S: 53-45 607-051-00-3 MCPA (ISO); 4-chloro-o-tolyloxyacetic acid 202-360-6 94-74-6 Xn; R22 Xi; R38-41 N; R50-53 Xn; N R: 22-38-41-50/53 S: (2-)26-37-39-60-61 607-052-00-9 salts and esters of MCPA A — — Xn; R20/21/22 N; R50-53 Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 607-085-00-9 benzyl benzoate 204-402-9 120-51-4 Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-)25-46-61 607-095-00-3 maleic acid 203-742-5 110-16-7 Xn; R22 Xi; R36/37/38 R43 Xn R: 22-36/37/38-43 S: (2-)24-26-28-37-46 C ≥ 25 %: Xn; R22-36/37/38-43 20 % ≤ C <25 %: Xi; R36/37/38-43 0,1 % ≤ C < 20 %: Xi; R43 607-103-00-5 succinic anhydride 203-570-0 108-30-5 Xn; R22 Xi; R36/37 Xn R: 22-36/37 S: (2-)25-46 C ≥ 5 %: Xn; R22-36/37 1 % ≤ C < 5 %: Xi; R36/37 607-142-00-8 propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate 203-687-7 109-61-5 F; R11 T; R23 C; R34 F; T R: 11-23-34 S: (1/2-)16-26-36-45 607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 R10 R: 10 S: (2-) 607-216-00-X glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine 403-950-8 — T+; R26 Xn; R22 C; R34 N; R50 T+; N R: 22-26-34-50 S: (1/2-)26-36/37/39-38-45-61 607-231-00-1 clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid 216-935-4 1702-17-6 Xi; R41 Xi R: 41 S: (2-)26-39 607-245-00-8 tert-butyl acrylate D 216-768-7 1663-39-4 F; R11 Xn; R20/21/22 Xi; R37/38 R43 N; R51-53 F; Xn; N R: 11-20/21/22-37/38-43-51/53 S: (2-)16-25-37-61 C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53 20 % ≤ C < 25 %: Xi; R37/38-43-52/53 2,5 % ≤ C < 20 %: Xi; R43-52/53 1 % ≤ C < 2,5 %: Xi; R43 607-397-00-5 A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) 415-930-6 — Repr. Cat. 3; R62 R43 Xn R: 43-62 S: (2-)23-36/37 608-005-00-5 n-butyronitrile 203-700-6 109-74-0 F; R11 T; R23/24/25 F; T R: 11-23/24/25 S: (1/2-)16-36/37-45-63 608-011-00-8 oxalonitrile; cyanogen 207-306-5 460-19-5 F+; R12 T; R23 N; R50-53 F+; T; N R: 12-23-50/53 S: (1/2-)9-16-23-33-45-63-60-61 608-044-00-8 2-cyclohexylidene-2-phenylacetonitrile 423-740-1 10461-98-0 Xn; R22 N; R51-53 Xn; N R; 22-51/53 S: (2-)46-61 609-007-00-9 2,4-dinitrotoluene; [1] dinitrotoluene [2] E 204-450-0 [1] 246-836-1 [2] 121-14-2 [1] 25321-14-6 [2] Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R23/24/25 Xn; R48/22 N; R50-53 T; N R: 45-23/24/25-48/22-62-68-50/53 S: 53-45-60-61 611-028-00-3 C,C′-azodi(formamide) 204-650-8 123-77-3 E; R2 R42 E; Xn R: 2-42 S: (2-)22-24-37 611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate 403-660-1 107246-80-0 N; R51-53 N R: 51/53 S: 61 612-044-00-3 N,N′-diacetylbenzidine E 210-338-2 613-35-4 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R20/21/22 T R: 45-20/21/22-68 S: 53-45 612-050-00-6 cyclohexylamine 203-629-0 108-91-8 R10 Repr. Cat. 3; R62 Xn; R21/22 C; R34 C R: 10-21/22-34-62 S: (1/2-)26-36/37/39-45 C ≥ 25 %: C; R21/22-34-62 10 % ≤ C < 25 %: C; R34-62 5 % ≤ C < 10 %: Xn; R36/38-62 2 % ≤ C < 5 %: Xi; R36/38 612-076-00-8 ethyldimethylamine 209-940-8 598-56-1 F; R11 Xn; R20/22 C; R34 F; C R: 11-20/22-34 S: (1/2-)3-16-26-36-45 612-099-00-3 4-methyl-m-phenylenediamine; 2,4-toluenediamine E 202-453-1 95-80-7 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 R43 N; R51-53 T; N R: 45-21-25-43-48/22-62-68-51/53 S: 53-45-61 612-101-00-2 methenamine; hexamethylenetetramine 202-905-8 100-97-0 F; R11 R43 F; Xi R: 11-43 S: (2-)24-37 612-151-00-5 methyl-phenylene diamine; diaminotoluene; [technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] E — — Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 Xi; R36 R43 N; R51-53 T; N R: 45-21-25-36-43-48/22-62-68-51/53 S: 53-45-61 612-237-00-2 hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] T 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] E; R2 Carc. Cat. 3; R40 Xn; R21/22-48/22 Xi; R36/38 R43 N; R50 E; Xn; N R: 21/22-36/38-40-43-48/22-50 S: (2-)36/37-61 613-116-00-7 tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 211-986-9 731-27-1 T+; R26 T; R48/23 Xi; R36/37/38 R43 N; R50 T+; N R: 26-36/37/38-43-48/23-50 S: (1/2-)28-36/37/39-45-63-61 C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50 10 % ≤ C < 20 %: T+, N; R26-43-48/23-50 7 % ≤ C < 10 %: T+, N; R26-43-48/20-50 2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50 1 % ≤ C < 2,5 %: T; R23-43-48/20 0,1 % ≤ C < 1 %: Xn; R20 615-001-00-7 methyl isocyanate 210-866-3 624-83-9 F; R11 Repr. Cat. 3; R63 T+; R26 T; R24/25 R42/43 Xi; R37/38-41 F; T+ R: 11-24/25-26-37/38-41-42/43-63 S: (1/2-)16-26-27/28-36/37/39-45-63 615-004-00-3 salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex A — — Xn; R20/21/22 R32 R52-53 Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate 410-220-2 77375-79-2 R14 Xn; R22-48/22 Xi; R41 R42/43 Xn R: 14-22-41-42/43-48/22 S: (2-)8-23-26-30-35-36/37/39 615-030-00-5 alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex A — — Xn; R20/21/22 R32 R52-53 Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 615-031-00-0 thallium thiocyanate 222-571-7 3535-84-0 T+; R26/28 Xn; R21 R32 R33 N; R51-53 T+; N R: 21-26/28-32-33-51/53 S: (1/2-)13-28-36/37-45-61 615-032-00-6 metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex A — — Xn; R20/21/22 R32 N; R50-53 Xn; N R: 20/21/22-32-50/53 S: (2-)13-36/37-46-60-61 616-124-00-9 lithium bis(trifluoromethylsulfonyl)imide 415-300-0 90076-65-6 T; R24/25 Xn; R48/22 C; R34 R52-53 T R: 24/25-34-48/22-52/53 S: (1/2-)22-26-36/37/39-45-61 617-017-00-X A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene; 2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene T 412-140-3 32144-25-5 E; R2 O; R7 R53 E R: 2-7-53 S: (2-)3/7-14-36/37/39-61 650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] AQR — — Carc. Cat. 3; R40 Xn R: 40 S: (2-)36/37 650-017-00-8 Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] AR — — Carc. Cat. 2; R49 T R: 49 S: 53-45

ANNEX 1B

Index No Chemical name Notes related to substances EC No CAS No Classification Labelling Concentration Limits Notes related to preparations 003-003-00-5 (2-methylpropyl)lithium; isobutyllithium 440-620-2 920-36-5 F; R15-17 R14 C; R35 R67 N; R50-53 F; C; N R: 14/15-17-35-67-50/53 S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 005-013-00-5 diethylmethoxyborane 425-380-9 7397-46-8 F; R17 Xn; R20/21/22-48/22 C; R34 R43 R53 F; C R: 17-20/21/22-34-43-48/22-53 S: (1/2-)6-26-36/37/39-43-45-61 005-014-00-0 4-formylphenylboronic acid 438-670-5 87199-17-5 R43 Xi R: 43 S: (2-)24-37 005-017-00-7 sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; [3] sodium peroxometaborate; [4] perboric acid (HBO(O2)), sodium salt, monohydrate; [5] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E 239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] 15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R22 Xi; R37-41 O; T R: 61-8-22-37-41-62 S: 53-45 C ≥ 25 %: T; R61-22-37-41-62 22 % ≤ C < 25 %: T; R61-37-41-62 20 % ≤ C < 22 %: T; R61-36/37-62 14 % ≤ C < 20 %: T; R61-36-62 9 % ≤ C < 14 %: T; R61-62 6,5 % ≤ C < 9 %: T; R61 005-017-01-4 sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; [3] sodium peroxometaborate; [4] perboric acid (HBO(O2)), sodium salt, monohydrate; [5] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E 239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] 15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T; R23 Xn; R22 Xi; R37-41 O; T R: 61-8-22-23-37-41-62 S: 53-45 C ≥ 25 %: T; R61-22-23-37-41-62 22 % ≤ C < 25 %: T; R61-20-37-41-62 20 % ≤ C < 22 %: T; R61-20-36/37-62 14 % ≤ C < 20 %: T; R61-20-36-62 9 % ≤ C < 14 %: T; R61-20-62 6,5 % ≤ C < 9 %: T; R61-20 3 % ≤ C < 6,5 %: Xn; R20 005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] - [1] - [2] - [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xi; R37-41 T R: 61-37-41-62 S: 53-45-47 C ≥ 36 %: T; R61-37-41-62 22 % ≤ C < 36 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E - [1] - [2] - [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R20 Xi; R37-41 T R: 61-20-37-41-62 S: 53-45-47 C ≥ 36 %: T; R61-20-37-41-62 25 % ≤ C < 36 %: T; R61-20-36/37-62 22 % ≤ C < 25 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 006-097-00-6 1-phenyl-3-(p-toluenesulfonyl)urea 424-620-1 13909-63-2 Xn; R22-48/22 R52-53 Xn R: 22-48/22-52/53 S: (2-)22-36-61 006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate 429-170-8 134575-17-0 Xn; R22-48/22 Xi; R41 R43 Xn R: 22-41-43-48/22 S: (2-)22-26-36/37/39 006-099-00-7 N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate 432-520-2 232938-43-1 N; R51-53 N R: 51/53 S: 22-61 006-101-00-6 mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea; N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea] 423-070-8 — R53 R: 53 S: 61 006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamate E 432-750-3 — Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R22-48/22 R43 N; R51-53 T; N R: 45-46-22-43-48/22-51/53 S: 53-45-61 006-103-00-7 N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea 445-760-8 — Xi; R41 R42 N; R50-53 Xn; N R: 41-42-50/53 S: (2-)22-26-39-45-60-61 C ≥10 %: Xn, N; R41-42-50/53 5 % ≤ C < 10 %: Xn, N; R36-42-50/53 1 % ≤ C < 5 %: Xn, N; R42-50/53 0,25 % ≤ C < 1 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 ≤ C < 0,025 %: R52/53 007-029-00-8 diethyldimethylammonium hydroxide 419-400-5 95500-19-9 Xn; R21/22 C; R35 C R: 21/22-35 S: (1/2-)26-36/37/39-45 012-004-00-X aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate 422-150-1 — N; R50-53 N R: 50/53 S: 60-61 014-036-00-X (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane 405-020-7 105024-66-6 Repr.Cat.2; R60 N; R50-53 T; N R: 60-50/53 S: 53-45-60-61 C ≥ 0,5 %: T, N; R60-50/53 0,025 % ≤ C < 0,5 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 014-037-00-5 2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime 433-360-6 34036-80-1 Xn; R48/22 R43 R52-53 Xn R: 43-48/22-52/53 S: (2-)36/37-61 014-038-00-0 S-(3-(triethoxysilyl)propyl)octanethioate 436-690-9 220727-26-4 R43 Xi R: 43 S: (2-)24-37 014-039-00-6 (2,3-dimethylbut-2-yl)-trimethoxysilane 439-360-2 142877-45-0 Xi; R38-41 R52-53 Xi R: 38-41-52/53 S: (2-)26-37/39-61 014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane 445-890-5 201290-01-9 Xn; R22 R43 Xn R: 22-43 S: (2-)24-37 014-042-00-2 mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) 423-010-0 — Xi; R41 Xi R: 41 S: (2-)26-39 014-043-00-8 reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) 432-200-2 — F; R11 Xi; R37/38-41 R52-53 F; Xi R: 11-37/38-41-52/53 S: (2-)6-26-36/39-61 014-044-00-3 3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane 433-050-0 — N; R51-53 N R: 51/53 S: 61 014-045-00-9 magnesium sodium fluoride silicate 442-650-1 — Xn; R48/20 Xn R: 48/20 S: (2-)22-36 015-190-00-0 bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 421-920-2 154862-43-8 R53 R: 53 S: 61 015-191-00-6 dodecyldiphenyl phosphate 431-760-5 27460-02-2 Xi; R38 R52-53 Xi R: 38-52/53 S: (2-)37-61 015-192-00-1 tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate 432-770-2 139189-30-3 R43 R53 Xi R: 43-53 S: (2-)24-37-61 015-193-00-7 triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) 442-960-7 332350-93-3 T; R25 Xi; R41 N; R50-53 T; N R: 25-41-50/53 S: (1/2-)26-39-45-60-61 015-194-00-2 tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate 444-440-5 220689-12-3 Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)61 015-195-00-8 mixture of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate 433-860-4 — Xi; R36 R43 R52-53 Xi R: 36-43-52/53 S: (2-)24-26-37-61 015-196-00-3 mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate 435-960-3 — Carc.Cat.2; R45 Muta.Cat.2; R46 R43 T R: 45-46-43 S: 53-45 015-197-00-9 bis(2,4,4-trimethylpentyl)dithiophosphonic acid 420-160-9 107667-02-7 R10 T; R23 Xn; R22 C; R34 N; R51-53 T; N R: 10-22-23-34-51/53 S: (1/2-)9-26-36/37/39-45-61 015-198-00-4 (4-phenylbutyl)phosphinic acid 420-450-5 86552-32-1 Carc.Cat.3; R40 Xi; R41 Xn R: 40-41 S: (2-)23-26-36/37/39 016-094-00-1 sulfur 231-722-6 7704-34-9 Xi; R38 Xi R: 38 S: (2-)46 016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride 434-480-1 32047-53-3 Xn; R22 C; R34 R43 R52-53 C R: 22-34-43-52/53 S: (1/2-)22-26-36/37/39-45-61 017-009-01-8 ammonium perchlorate; [containing < 80 % of 0-30 μm particles] T 232-235-1 7790-98-9 E; R2 O; R9 E R: 2-9 S: (2-)14-16-36/37 022-004-00-1 potassium titanium oxide (K2Ti6O13) 432-240-0 12056-51-8 Carc.Cat.3; R40 Xn R: 40 S: (2-)22-36/37 022-005-00-7 [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium 419-840-8 169104-71-6 F; R11 C; R34 R43 R53 F; C R: 11-34-43-53 S: (1/2-)6-9-16-26-36/37/39-45-61 028-002-01-4 nickel powder; [particle diameter < 1 mm] 231-111-4 7440-02-0 Carc. Cat. 3; R40 T; R48/23 R43 R52-53 T R: 40-43-48/23-52/53 S: (2-)36/37/39-45-61 028-013-00-7 nickel matte E, H 273-749-6 69012-50-6 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-014-00-2 slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate E 295-859-3 92129-57-2 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53 20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53 2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-015-00-8 slimes and sludges, copper electrolyte refining, decopperised E, H 305-433-1 94551-87-8 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 1; R61 Repr. Cat. 3; R62 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-62-68-50/53 S: 53-45-60-61 028-016-00-3 nickel diperchlorate; perchloric acid, nickel(II) salt E, H 237-124-1 13637-71-3 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 C; R34 R42/43 N; R50-53 T; N R: 49-61-34-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53 5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-017-00-9 nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] E, H 237-563-9 [1] 239-793-2 [2] 13842-46-1 [1] 15699-18-0 [2] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-018-00-4 nickel bis(sulfamidate); nickel sulfamate E, H 237-396-1 13770-89-3 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-019-00-X nickel bis(tetrafluoroborate) E, H 238-753-4 14708-14-6 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-021-00-0 nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] E, H 222-101-0 [1] 239-946-6 [2] 268-755-0 [3] 3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 028-022-00-6 nickel di(acetate); [1] nickel acetate [2] E, H 206-761-7 [1] 239-086-1 [2] 373-02-4 [1] 14998-37-9 [2] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-024-00-7 nickel dibenzoate E, H 209-046-8 553-71-9 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-025-00-2 nickel bis(4-cyclohexylbutyrate) E, H 223-463-2 3906-55-6 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-026-00-8 nickel(II) stearate; nickel(II) octadecanoate E, H 218-744-1 2223-95-2 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-027-00-3 nickel dilactate E, H — 16039-61-5 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-028-00-9 nickel(II) octanoate E, H 225-656-7 4995-91-9 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat 2; R61 T; R48/23 C; R35 R42/43 N; R50-53 T; C; N R: 49-61-35-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53 10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53 5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-029-00-4 nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] E, H 233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] 10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-030-00-X nickel hexafluorosilicate E, H 247-430-7 26043-11-8 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-031-00-5 nickel selenate E, H 239-125-2 15060-62-5 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-032-00-0 nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nickel(II) salt [8] E, H 238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] 14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-033-00-6 diammonium nickel hexacyanoferrate E, H — 74195-78-1 Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-034-00-1 nickel dicyanide E, H 209-160-8 557-19-7 Carc. Cat. 1; R49 T; R48/23 R42/43 R32 N; R50-53 T; N R: 49-32-42/43-48/23-50/53 S: 53-45-60-61 028-035-00-7 nickel chromate E, H 238-766-5 14721-18-7 Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-036-00-2 nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] E, H 244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] 21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-037-00-8 dinickel hexacyanoferrate E, H 238-946-3 14874-78-3 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-038-00-3 trinickel bis(arsenate); nickel(II) arsenate E, H 236-771-7 13477-70-8 Carc. Cat. 1; R45 T; R48/23 R43 N; R50-53 T; N R: 45-43-48/23-50/53 S: 53-45-60-61 028-039-00-9 nickel oxalate; [1] oxalic acid, nickel salt [2] E, H 208-933-7 [1] 243-867-2 [2] 547-67-1 [1] 20543-06-0 [2] Carc. Cat. 1; R49 T; R48/23 R43 N: R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-040-00-4 nickel telluride E, H 235-260-6 12142-88-0 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-041-00-X trinickel tetrasulfide E, H — 12137-12-1 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-042-00-5 trinickel bis(arsenite) E, H — 74646-29-0 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-043-00-0 cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] E, H 269-051-6 [1] 261-346-8 [2] - [3] 68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-044-00-6 nickel tin trioxide; nickel stannate E, H 234-824-9 12035-38-0 Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-045-00-1 nickel triuranium decaoxide E, H 239-876-6 15780-33-3 Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-046-00-7 nickel dithiocyanate E, H 237-205-1 13689-92-4 Carc. Cat. 1; R49 Muta. Cat. 3;R68 Repr. Cat. 2; R61 T; R48/23 R42/43 R32 N; R50-53 T; N R: 49-61-32-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-047-00-2 nickel dichromate E, H 239-646-5 15586-38-6 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1% ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 028-048-00-8 nickel(II) selenite E, H 233-263-7 10101-96-9 Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-049-00-3 nickel selenide E, H 215-216-2 1314-05-2 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-050-00-9 silicic acid, lead nickel salt E, H — 68130-19-8 Carc. Cat. 1: R49 Repr. Cat. 1: R61 Repr. Cat. 3; R62 T; R48/23 R43 N; R50-53 T; N R: 49-61-43-48/23-62-50/53 S: 53-45-60-61 028-051-00-4 nickel diarsenide; [1] nickel arsenide [2] E, H 235-103-1 [1] 248-169-1 [2] 12068-61-0 [1] 27016-75-7 [2] Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-052-00-X nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 E, H 271-853-6 68610-24-2 Carc. Cat. 1: R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-053-00-5 nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] E, H 267-897-0 [1] 238-596-1 [2] 275-897-7 [3] 67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T: R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-054-00-0 nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickel salt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt; [16] nickel(II) neoundecanoate; [17] bis(D-gluconato-O1,O2)nickel; [18] nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] (isononanoato-O)(isooctanoato-O)nickel; [22] (isooctanoato-O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] (isodecanoato-O)(isooctanoato-O)nickel; [26] (isodecanoato-O)(isononanoato-O)nickel; [27] (isononanoato-O)(neodecanoato-O)nickel; [28] fatty acids, C6-19-branched, nickel salts; [29] fatty acids, C8-18 and C18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] E, H 240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] 16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-055-00-6 nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] E, H 231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] 7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-056-00-1 nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] E, H 234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] 12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-057-00-7 dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] E, H 234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] 12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-058-00-2 cobalt lithium nickel oxide E 442-750-5 — Carc. Cat. 1; R49 T+; R26 T; R48/23 R43 N; R50-53 T+; N R: 49-26-43-48/23-50/53 S: 53-45-60-61 029-014-00-5 mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex; 2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex 419-610-7 171866-24-3 Xn; R48/22 N; R51-53 Xn; N R: 48/22-51/53 S: (2-)22-36-61 030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 423-570-6 169314-88-9 R52-53 R: 52/53 S: 61 030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate 440-060-9 — N; R51-53 N R: 51/53 S: 61 042-005-00-0 mixture of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex 434-240-6 — R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 050-023-00-5 mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane 422-920-5 — Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)23-36-60-61 C ≥ 10 %: Xn, N; R48/22-50/53 2,5 % ≤ C < 10 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 050-024-00-0 mixture of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane 432-230-6 — T; R48/25 Xn; R22 Xi; R38-41 R43 N; R50-53 T; N R: 22-38-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 064-001-00-8 gadolinium(III)sulfite trihydrate 456-900-2 51285-81-5 N; R51-53 N R: 51/53 S: 61 078-011-00-5 hydroxydisulfito platinum(II) acid 423-310-1 61420-92-6 Xn; R22-48/20/21/22 C; R35 R42/43 R52-53 C R: 22-35-42/43-48/20/21/22-52/53 S: (1/2-)23-24-26-28-36/37/39-45-61 078-012-00-0 platinum(IV) nitrate/nitric acid solution 432-400-1 — C; R35 N; R50-53 C; N R: 35-50/53 S: (1/2-)26-36/37/39-45-60-61 082-012-00-6 barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped 431-780-4 199876-46-5 Xn; R22-48/22 N; R51-53 Xn; N R: 22-48/22-51/53 S: (2-)22-36-61 601-080-00-5 mixture of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers 431-100-6 — N; R50-53 N R: 50/53 S: 60-61 601-081-00-0 cyclohexadeca-1,9-diene 431-730-1 4277-06-9 Xi; R38 R43 R53 Xi R: 38-43-53 S: (2-)36/37-61 601-082-00-6 mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane 434-420-4 — Xi; R38-41 N; R50-53 Xi; N R: 38-41-50/53 S: (2-)23-26-37/39-57-60-61 601-083-00-1 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene 435-000-3 22094-83-3 Xn; R65 Xi; R38 R53 Xn R: 38-65-53 S: (2-)37-62-61 601-084-00-7 mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) 435-180-3 — Xn; R65 Xi; R38 N; R50-53 Xn; N R: 38-65-50/53 S: (2-)37-62-60-61 602-105-00-2 sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate 422-100-7 102061-82-5 Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 602-106-00-8 2-bromo-4,6-difluoroaniline 429-430-0 444-14-4 Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-)25-61 602-107-00-3 3,3,4,4-tetrafluoro-4-iodo-1-butene 439-500-2 33831-83-3 Xn; R22 Xi; R38 N; R51-53 Xn; N R: 22-38-51/53 S: (2-)37-61 602-108-00-9 (2,3,5,6-tetrafluorophenyl)methanol 443-840-7 4084-38-2 Xn; R22 Xi; R36 R43 Xn R: 22-36-43 S: (2-)26-36/37 603-211-00-1 2,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … % B E 221-221-0 3033-77-0 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 Xn; R21/22-48/22 Xi; R41 R43 R52-53 T R: 45-21/22-41-43-48/22-62-68-52/53 S: 53-45-61 603-212-00-7 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) 214-946-9 1222-05-5 N; R50-53 N R: 50/53 S: 60-61 603-213-00-2 2-methoxy-2-methylbutane; tert-amyl methyl ether 213-611-4 994-05-8 F; R11 Xn; R22 R67 F; Xn R: 11-22-67 S: (2-)9-16-23-33 603-214-00-8 1,1-diisopropoxycyclohexane 413-740-8 1132-95-2 C; R34 C R: 34 S: (1/2-)23-26-36/37/39-45 603-215-00-3 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 418-330-2 162241-33-0 E; R2 Xn; R22-48/22 Xi; R41 R43 N; R50-53 E; Xn; N R: 2-22-41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol 422-660-2 7480-35-5 Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 603-217-00-4 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite 423-560-1 161717-32-4 R43 R53 Xi R: 43-53 S: (2-)24-37/39-61 603-220-00-0 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol 432-890-5 72955-94-3 R53 R: 53 S: 61 603-221-00-6 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] 433-580-2 214353-17-0 Xn; R22 C; R34 N; R51-53 C; N R: 22-34-51/53 S: (1/2-)26-36/37/39-45-61 603-221-01-3 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] E 433-580-2 214353-17-0 Carc. Cat. 2; R45 Xn; R22 C; R34 N; R51-53 T; N R: 45-22-34-51/53 S: 53-45-61 603-222-00-1 (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane 433-820-6 118058-74-5 Xi; R36 Xi R: 36 S: (2-)26 603-223-00-7 2-cyclopentylidene cyclopentanol; 1,1′-bi(cyclopentyliden)-2-ol 434-270-1 6261-30-9 Xi; R38-41 R52-53 Xi R: 38-41-52/53 S: (2-)26-37/39-61 603-224-00-2 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane 435-790-1 297730-93-9 R53 R: 53 S: 61 603-225-00-8 erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) 437-070-0 13127-18-9 N; R51-53 N R: 51/53 S: 61 603-226-00-3 4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol 444-500-0 1440-00-2 R52-53 R: 52/53 S: 61 603-227-00-9 α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate 445-060-2 203574-04-3 O; R7 N; R50-53 O; N R: 7-50/53 S: (2-)3/7-14-36/37/39-60-61 603-228-00-4 (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane 419-620-1 — R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)36/37-61 603-229-00-X sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate 420-800-7 — Xi; R38-41 R43 N; R50-53 Xi; N R: 38-41-43-50/53 S: (2-)24-26-37/39-60-61 603-230-00-5 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan 440-030-5 — Xi; R38-41 R53 Xi R: 38-41-53 S: (2-)26-37/39-61 603-231-00-0 (S)-1,1-diphenyl-1,2-propanediol 443-220-6 — R52-53 R: 52/53 S: 22-61 603-232-00-6 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane 444-420-6 — R53 R: 53 S: 61 603-233-00-1 mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol 444-430-0 — N; R51-53 N R: 51/53 S: 61 603-234-00-7 (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene 444-480-3 — Xi; R38 N; R51-53 Xi; N R: 38-51/53 S: (2-)37-61 604-074-00-0 tetrabromobisphenol-A; 2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol 201-236-9 79-94-7 N; R50-53 N R: 50/53 S: 60-61 604-075-00-6 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol 205-426-2 140-66-9 Xi; R38-41 N; R50-53 Xi; N R: 38-41-50/53 S: (2-)26-37/39-60-61 C ≥ 20 %: Xi, N; R38-41-50/53 10 % ≤ C < 20 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 604-076-00-1 phenolphthalein 201-004-7 77-09-8 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T R: 45-62-68 S: 53-45 C ≥ 5 %: T; R45-62-68 1 % ≤ C < 5 %: T; R45-68 604-077-00-7 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol 419-750-9 98809-58-6 R53 R: 53 S: 61 604-079-00-8 4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol 428-970-4 13595-25-0 Repr.Cat.3; R62 R43 N; R51-53 Xn; N R: 43-62-51/53 S: (2-)22-36/37-61 604-080-00-3 4-fluoro-3-trifluoromethylphenol 432-560-0 61721-07-1 Xn; R20 C; R35 R43 N; R51-53 C; N R: 20-35-43-51/53 S: (1/2-)26-28-36/37/39-45-61 604-081-00-9 1,1-bis(4-hydroxyphenyl)-1-phenylethane 433-130-5 1571-75-1 N; R50-53 N R: 50/53 S: 25-60-61 604-082-00-4 2-chloro-6-fluoro-phenol E 433-890-8 2040-90-6 Muta.Cat.2; R46 Repr.Cat.3; R62 Xn; R22 C; R34 R43 N; R51-53 T; N R: 46-22-34-43-62-51/53 S: 53-45-61 604-083-00-X 4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol 439-270-3 260408-02-4 R53 R: 53 S: 61 604-084-00-5 1-ethoxy-2,3-difluorobenzene 441-000-4 121219-07-6 Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)23-61 604-087-00-1 mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol 433-640-8 — F; R17 R44 R53 F R: 17-44-53 S: (2-)15-22-61 604-089-00-2 2-methyl-5-tert-butylthiophenol 444-970-7 — R10 Repr.Cat.3; R63 Xn; R48/20/22-65 Xi; R36/38 R43 R67 N; R50-53 Xn; N R: 10-36/38-43-48/20/22-63-65-67-50/53 S: (2-)26-36/37-62-60-61 605-037-00-1 trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde 421-800-1 120578-03-2 R53 R: 53 S: 22-61 605-038-00-7 3-methyl-5-phenylpentan-1-al 433-900-0 55066-49-4 Xn; R22 Xi; R38 R43 N; R51-53 Xn; N R: 22-38-43-51/53 S: (2-)36/37-61 605-039-00-2 3,4-dihydroxy-5-nitrobenzaldehyde 441-810-8 116313-85-0 Xn; R22 Xi; R41 R43 Xn R: 22-41-43 S: (2-)22-24-26-37/39 606-124-00-7 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione 421-080-7 161462-35-7 Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)36-60-61 606-125-00-2 1-benzylimidazolidine-2,4-dione 421-340-1 6777-05-5 Xn; R22 Xn R: 22 S: (2-)22 606-126-00-8 1,4-bis(2,3-dihydroxypropylamino)anthraquinone 421-470-7 99788-75-7 N; R51-53 N R: 51/53 S: 61 606-128-00-9 2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione 422-650-8 148935-94-8 R53 R: 53 S: 61 606-129-00-4 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one 423-090-7 156732-13-7 R53 R: 53 S: 61 606-130-00-X 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone 423-860-2 56309-94-5 R43 R52-53 Xi R: 43-52/53 S: (2-)24-37-61 606-131-00-5 cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione E 427-230-8 5571-36-8 Repr. Cat. 2; R60 Xn; R48/22 N; R51-53 T; N R: 60-48/22-51/53 S: 53-45-61 606-132-00-0 (6β)-6,19-epoxyandrost-4-ene-3,17-dione 433-490-3 6563-83-3 R43 R52-53 Xi R: 43-52/53 S: (2-)24-37-61 606-134-00-1 androsta-1,4,9(11)-triene-3,17-dione 433-560-3 15375-21-0 Repr. Cat.3; R62 Xn R: 62 S: (2-)22-36/37 606-135-00-7 cyclohexadecanone 438-930-8 2550-52-9 R53 R: 53 S: 61 606-136-00-2 (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone 444-350-6 133413-70-4 Xi; R36 R53 Xi R: 36-53 S: (2-)26-61 606-137-00-8 trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione 444-750-0 211387-26-7 R53 R: 53 S: 22-61 606-138-00-3 (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone 444-800-1 141645-23-0 R10 Xn; R22-48/22 Xi; R38-41 R43 N; R50-53 Xn; N R: 10-22-38-41-43-48/22-50/53 S: (2-)23-26-36/37/39-60-61 C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53 20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53 10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 606-139-00-9 (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one 444-830-5 124379-29-9 R53 R: 53 S: 61 606-140-00-4 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one 444-860-9 474510-57-1 Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 606-141-00-X sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate 418-410-7 — Xi; R36 Xi R: 36 S: (2-)26 606-142-00-5 mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one 434-290-9 — Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-)61 607-580-00-X ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 422-360-1 100491-29-0 R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)22-24-37-61 607-618-00-5 menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt 204-987-0 130-37-0 Xi; R36/38 N; R50-53 Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 607-619-00-0 menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) 277-543-7 73581-79-0 Xi; R36/38 N; R50-53 Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 607-620-00-6 trisodium nitrilotriacetate 225-768-6 5064-31-3 Carc. Cat. 3; R40 Xn; R22 Xi; R36 Xn R: 22-36-40 S: (2-)26-36/37-46 C ≥ 25 %: Xn; R22-36-40 20 ≤ % C < 25 %: Xn; R36-40 5 ≤ % C < 20 %: Xn; R40 607-621-00-1 milbemectin (ISO); [mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] — — Xn; R20/22 N; R50-53 Xn; N R: 20/22-50/53 S: (2-)46-60-61 C ≥ 25 %: Xn, N; R20/22-50/53 0,25 % ≤ C < 25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 607-622-00-7 2-ethylhexyl-2-ethylhexanoate 231-057-1 7425-14-1 Repr. Cat. 3; R63 Xn R: 63 S: (2-)36/37 607-623-00-2 diisobutyl phthalate 201-553-2 84-69-5 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T R: 61-62 S: 53-45 C ≥ 25 %: T; R61-62 5 % ≤ C < 25 %: Xn; R62 607-624-00-8 perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] E 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] Carc. Cat. 3; R40 Repr. Cat. 2; R61 T; R48/25 Xn; R20/22 R64 N; R51-53 T; N R: 61-20/22-40-48/25-64-51/53 S: 53-45-61 607-625-00-3 clodinafop-propargyl (ISO) — 105512-06-9 Xn; R22-48/22 R43 N; R50-53. Xn; N R: 22-43-48/22-50/53 S: (2-)24-36/37-46-60-61 C ≥ 25 %: Xn, N; R22-43-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53 2,5 % ≤ C < 10 %: Xi, N; R43-51/53 0,25 % ≤ C < 2,5 %: Xi; R43-52/53 0,001 % ≤ C < 0,25 %: Xi; R43 607-626-00-9 ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate 401-290-5 103112-35-2 Carc.Cat.2; R45 N; R50-53 T; N R: 45-50/53 S: 53-45-60-61 607-627-00-4 [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate 416-360-0 162221-28-5 R43 Xi R: 43 S: (2-)22-24-37 607-628-00-X 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine 419-240-6 171054-89-0 Xi; R41 Xi R: 41 S: (2-)26-39 607-629-00-5 [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid 419-270-1 123599-82-6 Xi; R36 Xi R: 36 S: (2-)26 607-630-00-0 acrylic acid, 3-(trimethoxysilyl)propyl ester 419-560-6 4369-14-6 Xn; R20 C; R34 R43 R52-53 C R: 20-34-43-52/53 S: (1/2-)26-36/37/39-45-61 607-631-00-6 mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate 442-300-8 — R43 Xi R: 43 S: (2-)24-37 607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide 420-210-1 111244-14-5 R53 R: 53 S: 61 607-633-00-7 trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate 440-480-2 341026-59-3 Xi; R41 R43 Xi R: 41-43 S: (2-)22-24-26-37/39 607-634-00-2 (S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate 420-610-4 36394-75-9 Xn; R22 C; R34 R43 C R: 22-34-43 S: (1/2-)23-26-36/37/39-45 607-635-00-8 trisodium N-(3-propionato)-L-aspartate 422-090-4 172737-80-3 Xi; R41 Xi R: 41 S: (2-)26-39 607-636-00-3 1-bromo-2-methylpropyl propionate 422-900-6 158894-67-8 R10 Carc.Cat.3; R40 C; R34 R43 C R: 10-34-40-43 S: (1/2-)7/9-8-23-26-36/37/39-45 607-637-00-9 disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate 423-730-5 250688-43-8 Xi; R41 Xi R: 41 S: (2-)26-39 607-638-00-4 2-hydroxybenzoic acid 2-butyloctyl ester 431-090-3 190085-41-7 R53 R: 53 S: 61 607-639-00-X 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate 431-770-1 216698-07-6 R53 R: 53 S: 61 607-641-00-0 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid 431-930-9 43028-69-9 Xn; R22 R43 Xn R: 22-43 S: (2-)22-24-37 607-642-00-6 3,6,9-trithiaundecamethylene-1,11-dimethacrylate 432-210-7 141631-22-3 N; R50-53 N R: 50/53 S: 60-61 607-643-00-1 dimethyl (2S)-2-hydroxysuccinate 432-310-0 617-55-0 R10 Xi; R41 R43 Xi R: 10-41-43 S: (2-)24-26-37/39-43 607-644-00-7 methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate 432-350-9 81752-87-6 Xi; R38 Xi R: 38 S: (2-)37 607-645-00-2 tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate 432-550-6 243858-01-7 Xi; R41 Xi R: 41 S: (2-)22-26-39 607-646-00-8 D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate 432-960-5 124655-09-0 Xn; R22 Xn R: 22 S: (2-)25 607-647-00-3 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane 433-530-1 143446-73-5 Xn; R22 R43 N; R50 Xn; N R: 22-43-50 S: (2-)24-37-57-61 607-649-00-4 [3-(chlorocarbonyl)-2-methylphenyl]acetate 433-690-0 167678-46-8 C; R35 R43 C R: 35-43 S: (1/2-)7/8-26-36/37/39-45 607-650-00-X 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate 433-910-5 145153-52-2 R43 Xi R: 43 S: (2-)24-37 607-651-00-5 sodium 2-(nonanoyloxy)benzenesulfonate 434-360-9 91125-43-8 Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 607-652-00-0 ethyl N2-dodecanoyl-L-argininate hydrochloride 434-630-6 60372-77-2 Xi; R41 N; R50 Xi; N R: 41-50 S: (2-)26-39-61 607-653-00-6 tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate 434-840-8 225786-91-4 N; R51-53 N R: 51/53 S: 61 607-654-00-1 (S)-3-hydroxy-γ-butyrolactone 434-990-4 7331-52-4 R43 Xi R: 43 S: (2-)23-24-37 607-655-00-7 ethyl 6,8-dichlorooctanoate 435-080-1 1070-64-0 R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 607-656-00-2 sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid 435-350-7 141250-43-3 Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 607-657-00-8 pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate 436-920-8 172399-10-9 Xi; R41 Xi R: 41 S: (2-)22-26-39 607-658-00-3 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt 440-770-9 371921-63-0 Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)26-39-61 607-659-00-9 pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid 442-030-0 321912-47-4 Xi; R41 Xi R: 41 S: (2-)22-26-39 607-660-00-4 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt 442-230-8 321679-52-1 Xi; R41 Xi R: 41 S: (2-)22-26-39 607-661-00-X 1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate 442-850-9 114772-40-6 R43 R53 Xi R: 43-53 S: (2-)22-24-37-61 607-662-00-5 methyl 2-(acetylamino)-3-chloropropionate 442-860-3 87333-22-0 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-60-61 607-663-00-0 bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate 442-980-6 127474-91-3 R53 R: 53 S: 61 607-664-00-6 methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate 443-120-2 393509-79-0 Xi; R41 N; R51-53 Xi; N R: 41-51/53 S: (2-)26-39-61 607-665-00-1 trans-methyl-2-ethyl-but-2-enoate 443-150-6 101226-85-1 R10 R: 10 S: 23 607-666-00-7 (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid 443-560-5 88784-33-2 Xi; R36 Xi R: 36 S: (2-)26 607-667-00-2 chloro-1-ethylcyclohexyl carbonate 444-950-8 99464-83-2 Muta.Cat.3; R68 R43 Xn R: 43-68 S: (2-)23-36/37 607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane 445-770-2 42031-28-7 Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 607-669-00-3 methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate 445-990-9 376588-17-9 R43 R53 Xi R: 43-53 S: (2-)24-37-61 607-670-00-9 dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate 448-700-9 500791-70-8 Xn; R48/22 Xi; R41 R43 N; R50-53 Xn; N R: 41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 C ≥ 10 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 607-671-00-4 diethyl 1,4-cyclohexanedicarboxylate 417-310-0 72903-27-6 N; R51-53 N R: 51/53 S: 61 607-672-00-X mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate 419-000-0 — R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 607-673-00-5 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate 419-570-0 — Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)61 607-674-00-0 branched C10-alkyl benzoates 421-090-1 131298-44-7 Xn; R20 Xn R: 20 S: (2-)23 607-675-00-6 mixture of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid 422-260-8 — Xi; R41 N; R50-53 Xi; N R: 41-50/53 S: (2-)26-39-60-61 607-676-00-1 mixture of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid 423-670-1 — Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 607-677-00-7 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate 424-660-8 — Xn; R48/22 Xi; R41 R43 Xn R: 41-43-48/22 S: (2-)22-26-36/37/39 607-678-00-2 mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate 427-090-8 — R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)23-25-36/37-61 607-679-00-8 mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) 431-440-5 — Xi; R41 N; R51-53 Xi; N R: 41-51/53 S: (2-)22-26-39-61 607-680-00-3 tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate 432-810-9 — R53 R: 53 S: 61 607-681-00-9 mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate 432-910-2 — R53 R: 53 S: 61 607-682-00-4 complex mixture of Chinese gum rosin post reacted with acrylic acid 434-230-1 144413-22-9 R53 R: 53 S: 61 607-683-00-X mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) 435-450-0 — R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 607-684-00-5 alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts 435-660-2 243662-67-1 Xi; R38 R43 Xi R: 38-43 S: (2-)24-37 607-685-00-0 ammonium 2-cocoyloxyethanesulfonate 441-050-7 — Xi; R38-41 Xi R: 38-41 S: (2-)26-37/39 607-686-00-6 6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) 441-550-5 — E; R2 F; R11 Carc. Cat. 3; R40 E; Xn R: 2-11-40 S: (2-)7-22-36/37 607-687-00-1 mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) 442-800-6 — Xi; R38 N; R51-53 Xi; N R: 38-51/53 S: (2-)37-61 607-688-00-7 (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride 444-320-2 — Xn; R22 Xn R: 22 S: (2-) 607-689-00-2 mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (para-isomer including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate (meta-isomer including cis- and trans-isomers) 444-920-4 — R52-53 R: 52/53 S: 61 607-690-00-8 dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate 432-860-1 255387-46-3 R43 Xi R: 43 S: (2-)24-37 607-691-00-3 magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear 448-690-6 — R53 R: 53 S: 61 607-692-00-9 zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear 446-470-4 — R53 R: 53 S: 61 607-693-00-4 hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate 443-860-6 302776-68-7 R53 R: 53 S: 61 607-694-00-X ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate 443-870-0 163520-33-0 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)22-36/37-60-61 608-042-00-7 (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide 421-810-4 194602-27-2 Xn; R22 Xi; R41 R43 N; R51-53 Xn; N R: 22-41-43-51/53 S: (2-)24-26-37/39-61 608-059-00-X 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile 421-240-6 120068-79-3 N; R51-53 N R: 51/53 S: 22-61 608-060-00-5 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile 421-300-1 138564-59-7 N; R50-53 N R: 50/53 S: 22-60-61 608-062-00-6 2-fluoro-4-hydroxybenzonitrile 422-810-7 82380-18-5 Xn; R22 Xi; R41 N; R51-53 Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 608-063-00-1 (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile 441-070-6 61826-76-4 T; R25 Xi; R41 R43 N; R50-53 T; N R: 25-41-43-50/53 S: (1/2-)9-26-36/37/39-45-60-61 608-064-00-7 cyanomethyltrimethylammoniummethylsulfate 433-720-2 — R52-53 R: 52/53 S: 61 609-069-00-7 musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone 201-328-9 81-14-1 Carc. Cat. 3; R40 N; R50-53 Xn; N R: 40-50/53 S: (2-)36/37-46-60-61 611-154-00-9 trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate 403-670-6 92408-46-3 R52-53 R: 52/53 S: 61 611-155-00-4 4,4′-oxybis(benzenesulfonylazide) 431-850-4 7456-68-0 E; R3 F; R11 Xn; R48/22 N; R50-53 E; Xn; N R: 3-11-48/22-50/53 S: (2-)14-22-33-35-36-60-61 611-156-00-X triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate 432-270-4 221354-37-6 Repr. Cat. 3; R62 Xn; R48/22 N; R51-53 Xn; N R: 48/22-62-51/53 S: (2-)36/37-61 611-157-00-5 benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate 432-590-4 243869-48-9 Xi; R36 R52-53 Xi R: 36-52/53 S: (2-)26-61 611-158-00-0 reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride 421-520-8 — F; R11 R53 F R: 11-53 S: (2-)3-12-16-33-61 611-159-00-6 disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate 421-880-6 — Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)26-39-61 611-160-00-1 mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane; 1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) 422-760-6 — F; R11 R53 F R: 11-53 S: (2-)3-12-33-61 611-161-00-7 trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III) 423-100-1 — Xi; R41 Xi R: 41 S: (2-)26-39 611-162-00-2 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) 429-600-4 — Xn; R22 Xi; R41 N; R51-53 Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 611-163-00-8 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate 429-610-9 — Xn; R22 Xi; R41 N; R51-53 Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 611-164-00-3 mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile; 2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile); 2,2′-dimethyl-2,2′-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile) 429-710-2 — R10 R32 R44 Xn; R22 N; R51-53 Xn; N R: 10-22-32-44-51/53 S: (2-)12-15-16-47-51-61 611-165-00-9 mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 431-830-5 — R52-53 R: 52/53 S: 61 611-166-00-4 mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 432-100-9 — Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)26-39-61 611-167-00-X sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II) 435-240-9 — R52-53 R: 52/53 S: 61 611-168-00-5 mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid 435-440-6 — Xi; R41 Xi R: 41 S: (2-)22-26-39 611-169-00-0 sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate 435-800-2 — R52-53 R: 52/53 S: 61 611-170-00-6 mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II) 435-880-9 — R52-53 R: 52/53 S: 22-61 611-171-00-1 mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate 436-890-6 — Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 611-172-00-7 mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate 438-310-7 — E; R2 Repr. Cat. 3; R62 Xn; R22-48/22 R52-53 E; Xn R: 2-22-48/22-62-52/53 S: (2-)22-35-36/37-61 611-173-00-2 mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt 440-510-4 — Xi; R41 R43 Xi R: 41-43 S: (2-)22-26-36/37/39 611-174-00-8 mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt 442-290-5 457624-86-1 Xi; R41 Xi R: 41 S: (2-)22-26-39 611-175-00-3 mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate 444-050-5 — Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 611-176-00-9 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate 444-250-2 — E; R2 F; R11 N; R51-53 E; N R: 2-11-51/53 S: (2-)22-61 611-177-00-4 mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III); tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III); trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III) 444-290-0 508202-43-5 Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)22-24-26-37/39-61 611-178-00-X mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 445-280-9 — Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 611-179-00-5 mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate 450-010-8 — Xi; R41 R43 Xi R: 41-43 S: (2-)22-24-26-37/39 611-180-00-0 iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts 417-850-7 — N; R51-53 N R: 51/53 S: 22-61 612-238-00-8 (3-chloro-2-hydroxypropyl) trimethylammonium chloride … % B 222-048-3 3327-22-8 Carc. Cat. 3, R40 R52-53 Xn R: 40-52/53 S: 36/37-61 612-239-00-3 biphenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine 202-110-6 91-95-2 Carc. Cat. 2; R45 Muta. Cat. 3; R68 T R: 45-68 S: 53-45 612-240-00-9 pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline — 53112-28-0 N; R51-53 N R: 51/53 S: 61 612-241-00-4 piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] Repr. Cat. 3; R62-63 Xi; R36/38 R42/43 R52-53 Xn R: 36/38-42/43-62-63-52/53 S: (1/2-)22-36/37-45-63-61 612-242-00-X cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine — 121552-61-2 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-46-60-61 C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-243-00-5 (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate 420-560-3 79617-97-3 Xi; R41 N; R50-53 Xi; N R: 41-50/53 S: (2-)26-39-60-61 C ≥ 10 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2, 5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-244-00-0 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride 421-310-6 87691-88-1 Repr. Cat. 3; R62 Xn; R22 Xi; R36 R43 N; R50-53 Xn; N R: 22-36-43-62-50/53 S: (2-)22-26-36/37/39-60-61 612-245-00-6 2-ethylphenylhydrazine hydrochloride 421-460-2 19398-06-2 Carc. Cat. 3; R40 T; R48/25 Xn; R22 Xi; R41 R43 N; R50-53 T; N R: 22-40-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53 10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53 5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-246-00-1 (2-chloroethyl)(3-hydroxypropyl)ammonium chloride E 429-740-6 40722-80-3 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/22 R43 R52-53 T R: 45-46-43-48/22-52/53 S: 53-45-61 612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide 423-530-8 152828-23-4 T; R48/25 Xn; R22 R52-53 T R: 22-48/25-52/53 S: (1/2-)22-36-45-61 612-248-00-2 reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) 439-540-0 — Xi; R38 R43 R53 Xi R: 38-43-53 S: (2-)24-37-61 612-249-00-8 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride 425-030-5 159939-85-2 Repr. Cat. 3; R62 Xn; R22 C; R34 R43 N; R51-53 C; N R: 22-34-43-62-51/53 S: (1/2-)22-26-36/37/39-45-61 612-250-00-3 chloro-N,N-dimethylformiminium chloride E 425-970-6 3724-43-4 R14 Repr. Cat. 2; R61 Xn; R22 C; R35 T; C R: 61-14-22-35 S: 53-45 612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride 426-020-3 51229-78-8 F; R11 Repr. Cat. 3; R63 Xn; R22 Xi; R38 R43 N; R51-53 F; Xn; N R: 11-22-38-43-63-51/53 S: (2-)7-22-33-36/37-61 612-252-00-4 imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine 428-040-8 138261-41-3 Xn; R22 N; R50-53 Xn; N R: 22-50/53 S: (2-)22-57-60-61 612-253-00-X 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] 429-400-7 199327-61-2 R52-53 R: R52/53 S: 61 612-253-01-7 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] 429-400-7 199327-61-2 Repr. Cat. 2; R61 R52-53 T R: 61-52/53 S: 53-45-61 612-254-00-5 reaction products of diisopropanolamine with formaldehyde (1:4) 432-440-8 220444-73-5 Carc. Cat. 3; R40 Xn; R22 C; R34 R43 N; R51-53 C; N R: 22-34-40-43-51/53 S: (1/2-)13-25-26-36/37/39-45-61 612-255-00-0 1-(3-methoxypropyl)-4-piperidinamine 431-950-8 179474-79-4 Xn; R21/22 C; R34 R52-53 C R: 21/22-34-52/53 S: (1/2-)26-36/37/39-45-61 612-256-00-6 benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate 427-470-3 137864-22-3 Xn; R22 R43 Xn R: 22-43 S: (2-)36/37 612-257-00-1 tripropylammonium dihydrogenphosphate 433-700-3 35687-90-2 Xn; R22 Xn R: 22 S: (2-)22 612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine 437-720-3 227085-51-0 Xi; R41 Xi R: 41 S: (2-)26-39 612-261-00-3 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline 441-190-9 121451-05-6 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-265-00-5 bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate 444-360-0 191617-13-7 R52-53 R: 52/53 S: 61 612-266-00-0 3-chloro-4-(3-fluorobenzyloxy)aniline 445-590-4 202197-26-0 Muta. Cat. 3; R68 Xn; R22-48/22 N; R50-53 Xn; N R: 22-48/22-68-50/53 S: (2-)22-36/37-60-61 612-267-00-6 bis(hydrogenated tallow C16-18-alkyl)hydroxylamine 418-370-0 — R43 R53 Xi R: 43-53 S: (2-)36/37-61 612-269-00-7 mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline 420-720-2 — R53 R: 53 S: 22-61 612-270-00-2 (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride 433-010-2 — Xn; R22 R43 R52-53 Xn R: 22-43-52/53 S: (2-)22-36/37-61 612-271-00-8 mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate 434-970-5 160987-57-5 R53 R: 53 S: 61 612-272-00-3 ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate 435-210-5 — N; R51-53 N R: 51/53 S: 61 612-273-00-9 alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride 435-650-8 — Xn; R22 C; R35 N; R50-53 C; N R: 22-35-50/53 S: (1/2-)26-36/37/39-45-60-61 612-274-00-4 (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate 445-750-3 — Xn; R22 Xi; R41 R43 R52-53 Xn R: 22-41-43-52/53 S: (2-)22-24-26-37/39-61 612-275-00-X fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil 447-880-6 206565-89-1 Xi; R38-41 R43 N; R50-53 Xi; N R: 38-41-43-50/53 S: (2-)23-26-36/37/39-60-61 C ≥ 20 %: Xi, N; R38-41-43-50/53 10 % ≤ C < 20 %: Xi, N; R41-43-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-276-00-5 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts 451-430-4 500717-36-2 Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)22-24-26-36/37/39-61 612-277-00-0 mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium 451-440-9 586372-44-3 Xi; R41 Xi R: 41 S: (2-)22-26-39 612-278-00-6 ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide 214-984-6 1239-45-8 Muta. Cat. 3; R68 T+; R26 Xn; R22 T+ R: 22-26-68 S: (1/2-)28-36/37-45-63 612-279-00-1 (R,S)-2-amino-3,3-dimethylbutane amide 447-860-7 144177-62-8 Repr. Cat. 3; R62 Xn; R48/22 Xi; R36/38 R43 Xn R: 36/38-43-48/22-62 S: (2-)22-26-36/37 612-280-00-7 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine H 205-057-7 132-32-1 Carc. Cat. 2; R45 T R: 45 S: 53-45 613-116-01-4 tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 211-986-9 731-27-1 Xi; R36/37/38 R43 N; R50 Xi; N R: 36/37/38-43-50 S: (2-)25-36/37-46-61 C ≥ 20 %: Xi, N; R36/37/38-43-50 2,5 % ≤ C < 20 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 613-280-00-X tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea 230-625-6 7226-23-5 Repr. Cat. 3; R62 Xn; R22 Xi; R41 Xn R: 22-41-62 S: 26-36/37/39 613-281-00-5 quinoline E 202-051-6 91-22-5 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R21/22 Xi; R36/38 N; R51-53 T; N R: 45-21/22-36/38-68-51/53 S: 53-45-61 613-282-00-0 triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol — 131983-72-7 N; R51-53 N R: 51/53 S: 61 613-283-00-6 ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone E 265-667-4 65277-42-1 Repr. Cat. 2; R60 T; R25 Xn; R48/22 N; R50-53 T; N R: 60-25-48/22-50/53 S: 53-45-60-61 613-284-00-1 metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol — 125116-23-6 Repr. Cat. 3; R63 Xn; R22 N; R51-53 Xn; N R: 22-63-51/53 S: (2-)36/37-46-61 613-285-00-7 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] 219-989-7 [1] 219-989-7 [2] 2592-95-2 [1] 123333-53-9 [2] E; R2 E R: 2 S: 16-35 613-286-00-2 potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] 418-260-2 183196-57-8 R43 Xi R: 43 S: (2-)24-37 613-286-01-X potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] 418-260-2 183196-57-8 Repr. Cat. 2; R61 R43 T R: 61-43 S: 53-45 613-287-00-8 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole 419-540-7 160194-26-3 Xn; R22 R43 N; R51-53 Xn; N R: 22-43-51/53 S: (2-)24-37-61 613-288-00-3 1,3-bis(dimethylcarbamoyl)-imidazolium chloride 420-930-4 135756-61-5 Xn; R22 Xi; R41 R52-53 Xn R: 22-41-52/53 S: (2-)22-26-37/39-61 613-289-00-9 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole 432-020-4 142623-48-1 N; R50-53 N R: 50/53 S: 60-61 613-290-00-4 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride 432-470-1 189012-93-9 Xi; R41 R43 N; R50-53 Xi; N R: 41-43-50/53 S: (2-)24-26-37/39-60-61 613-291-00-X 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one 434-820-9 106461-41-0 Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 613-292-00-5 N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine 435-010-8 26157-73-3 Muta. Cat. 3; R68 R52-53 Xn R: 68-52/53 S: (2-)36/37-61 613-293-00-0 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester 448-050-6 444065-11-6 R53 R: 53 S: 61 613-294-00-6 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester 448-260-8 379268-96-9 R53 R: 53 S: 61 613-295-00-1 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride 448-720-8 363138-44-7 Xn; R22 Xi; R41 R52-53 Xn R: 22-41-52/53 S: (2-)22-26-39-61 613-296-00-7 pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate 418-270-7 — R43 R52-53 Xi R: 43-52/53 S: (2-)24-37-47-61 613-297-00-2 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole 420-820-6 — R10 Xn; R22 N; R51-53 Xn; N R: 10-22-51/53 S: (2-)16-61 613-298-00-8 bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate 421-560-6 — Xn; R48/22 Xi; R41 N; R51-53 Xn; N R: 41-48/22-51/53 S: (2-)22-26-36/39-61 613-299-00-3 main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt 422-610-1 — Xi; R41 Xi R: 41 S: (2-)22-26-39 613-300-00-7 1-imidazol-1-yl-octadecan-2-ol 434-120-3 — R43 R53 Xi R: 43-53 S: (2-)24-37-61 613-301-00-2 dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate 443-910-7 — R53 R: 53 S: 61 613-302-00-8 disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate 432-980-4 243858-60-8 Xi; R41 Xi R: 41 S: (2-)22-26-39 613-303-00-3 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine 429-800-1 95737-68-1 N; R50-53 N R: 50/53 S: 60-61 613-304-00-9 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide 421-170-6 138937-28-7 Xn; R22 Xi; R41 Xn R: 22-41 S: (2-)22-26-39 613-305-00-4 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole 448-630-9 3147-77-1 R53 R: 53 S: 61 613-306-00-X (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate 433-520-5 82911-69-1 Xn; R22 R43 N; R51-53 Xn; N R: 22-43-51/53 S: (2-)24-37-61 613-307-00-5 clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine — 210880-92-5 Xn; R22 N; R50-53 Xn; N R: 22-50/53 S: (2-)46-60-61 C ≥ 25 %: Xn, N; R22-50/53 2,5 % ≤ C < 25 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 613-308-00-0 2-amino-5-methylthiazole 423-800-5 7305-71-7 Xn; R22-48/22 N; R50-53 Xn; N R: 22-48/22-50/53 S: (2-)22-36-60-61 613-309-00-6 1-methyl-3-phenyl-1-piperazine 431-180-2 5271-27-2 Xn; R21/22 Xi; R38-41 R52-53 Xn R: 21/22-38-41-52/53 S: (2-)26-36/37/39-61 613-310-00-1 (-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride 432-360-3 105813-13-6 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)22-24-37-60-61 613-311-00-7 methyl-5-nitrophenyl-guanidine 435-500-1 152460-07-6 Xn; R22 Xi; R36 R43 R52-53 Xn R: 22-36-43-52/53 S: (2-)22-24-26-37-61 613-312-00-2 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride 420-200-5 — Xn; R22 Xi; R41 R43 R52-53 Xn R: 22-41-43-52/53 S: (2-)22-26-36/37/39-61 613-313-00-8 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione 442-780-9 173838-67-0 R52-53 R: 52/53 S: 61 613-314-00-3 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one 443-770-7 7693-82-5 N; R50-53 N R: 50/53 S: 22-24-60-61 613-315-00-9 tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate 430-390-1 — Xn; R20 R52-53 Xn R: 20-52/53 S: (2-)25-61 613-316-00-4 trimethylopropane tri(3-aziridinylpropanoate); (TAZ) H 257-765-0 52234-82-9 Muta. Cat. 3; R68 Xi; R41 R43 Xn R: 41-43-68 S: 26-36/37/39-42 615-044-00-1 4-chlorophenylisocyanate 203-176-9 104-12-1 T+; R26 Xn; R22 Xi; R37/38-41 R42 N; R50-53 T+; N R: 22-26-37/38-41-42-50/53 S: (1/2-)26-28-36/37/39-45-63-60-61 615-045-00-7 4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) 420-530-1 — R42/43 R53 Xn R: 42/43-53 S: (2-)23-24-37-45-61 616-126-00-X 1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide 423-960-6 139756-01-7 Xn; R22-48/22 R52-53 Xn R: 22-48/22-52/53 S: (2-)22-36/37-61 616-164-00-7 dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide — 149961-52-4 Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20 N; R50-53 Xn; N R: 20-40-63-50/53 S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R20-40-63-50/53 5 % ≤ C < 25 %: Xn, N; R40-63-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52-53 616-165-00-2 beflubutamid (ISO); (RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide — 113614-08-7 N; R50-53 N R: 50/53 S: 60-61 C ≥ 0,25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 616-166-00-8 cyazofamid (ISO); 4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide — 120116-88-3 N; R50-53 N R: 50/53 S: 60-61 C ≥ 2,5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51-53 0,025 % ≤ C < 0,25 %: R52/53 616-167-00-3 N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide 418-290-6 168612-06-4 Xi; R36 R43 Xi R: 36-43 S: (2-)24-26-37 616-168-00-9 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium 418-440-0 136997-71-2 R43 Xi R: 43 S: (2-)22-24-37 616-169-00-4 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one 420-220-4 92771-56-7 R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-170-00-X (2R)-2-amino-2-phenylacetamide 420-370-0 6485-67-2 Xi; R36 R43 Xi R: 36-43 S: (2-)22-26-36/37 616-171-00-5 2-(para-chlorophenyl)glycineamide 420-830-0 102333-75-5 Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 616-172-00-0 N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl 423-840-3 14691-89-5 Xn; R22 Xn R: 22 S: (2-)22 616-174-00-1 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride 424-560-4 151257-01-1 Xn; R22 Xi; R36 Xn R: 22-36 S: (2-)22-26 616-175-00-7 2-(2-hexyldecyloxy)benzamide 431-230-3 202483-62-3 R53 R: 53 S: 61 616-176-00-2 3-N,N-bis(methoxyethyl)aminoacetanilide 432-530-7 24294-01-7 Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)22-24-61 616-177-00-8 (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide 432-970-1 217324-98-6 R53 R: 53 S: 61 616-178-00-3 N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide 434-500-9 52583-35-4 R53 R: 53 S: 22-61 616-179-00-9 2-chloro-N-(4-methylphenyl)acetamide 435-170-9 16634-82-5 Xi; R41 R43 N; R50-53 Xi; N R: 41-43-50/53 S: (2-)22-26-36/37/39-60-61 616-180-00-4 N,N-(dimethylamino)thioacetamide hydrochloride 435-470-1 27366-72-9 Repr. Cat. 2; R61 N; R50-53 T; N R: 61-50/53 S: 53-45-60-61 616-181-00-X 4′-methyldodecane-1-sulfonanilide 435-490-9 17417-32-2 N; R50-53 N R: 50/53 S: 60-61 616-182-00-5 N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide 435-860-1 214417-91-1 R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 616-183-00-0 N-dodecyl-4-methoxybenzamide 442-340-6 1854-15-5 R53 R: 53 S: 61 616-184-00-6 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide 442-560-2 105043-55-8 R53 R: 53 S: 61 616-186-00-7 N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide) 443-010-4 53641-10-4 R52-53 R: 52/53 S: 61 616-188-00-8 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide 443-980-9 221215-20-9 R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-189-00-3 N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide 444-780-4 452962-97-9 R53 R: 53 S: 61 616-190-00-9 N-decyl-4-nitrobenzamide 445-880-0 64026-19-3 R53 R: 53 S: 61 616-191-00-4 2-ethyl-N-methyl-N-(3-methylphenyl)butanamide 446-190-2 406488-30-0 Xn; R22 Xi; R36/38 R43 N; R51-53 Xn; N R: 22-36/38-43-51/53 S: (2-)24-26-37-61 616-192-00-X 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide 448-060-0 727678-39-9 R53 R: 53 S: 61 616-193-00-5 N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide 449-940-7 368450-39-9 R53 R: 53 S: 61 616-194-00-0 2,2-diethoxy-N,N-dimethylacetamide 449-950-1 34640-92-1 Xi; R36 Xi R: 36 S: (2-)26 616-196-00-1 disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide 419-990-4 — N; R50-53 N R: 50/53 S: 60-61 616-197-00-7 mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide 422-500-1 — Xn; R48/22 Xn R: 48/22 S: (2-)22-36 616-198-00-2 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene 423-300-7 — R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-200-00-1 mixture of: N,N′-ethane-1,2-diylbis(hexanamide); 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide; N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide) 432-430-3 — R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-201-00-7 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine 432-840-2 220926-97-6 Xn; R20 R53 Xn R: 20-53 S: (2-)22-61 616-202-00-2 mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide 434-330-5 — Carc. Cat. 3; R40 R43 R53 Xn R: 40-43-53 S: (2-)36/37-61 616-203-00-8 mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide 442-280-0 — R53 R: 53 S: 61 616-204-00-3 N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea] 451-060-3 122886-55-9 R53 R: 53 S: 61 617-022-00-7 mixture of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate 442-480-8 — O; R7 Xn; R22 C; R34 R43 N; R51-53 O; C; N R: 7-22-34-43-51/53 S: (1/2-)3/7-14-26-36/37/39-45-50-61 647-017-00-5 laccase 420-150-4 80498-15-3 R42 Xn R: 42 S: (2-)23-45

ANNEX 1C

The entries in Annex I with the following Index numbers are deleted: 024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.

Versions

1. 2009-01-15